Forte Biosciences Shares Owned By Institutions vs. Return On Asset
| FBRX Stock | USD 16.08 0.08 0.50% |
For Forte Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Forte Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Forte Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Forte Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Forte Biosciences over time as well as its relative position and ranking within its peers.
Forte |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forte Biosciences. If investors know Forte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forte Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.38) | Return On Assets (0.81) | Return On Equity (1.71) |
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Forte Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Forte Biosciences Return On Asset vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Forte Biosciences's current stock value. Our valuation model uses many indicators to compare Forte Biosciences value to that of its competitors to determine the firm's financial worth. Forte Biosciences is rated # 4 in shares owned by institutions category among its peers. It is rated below average in return on asset category among its peers . Return On Assets is likely to drop to -0.85 in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Forte Biosciences' earnings, one of the primary drivers of an investment's value.Forte Return On Asset vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Forte Biosciences |
| = | 54.05 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Forte Biosciences |
| = | -0.81 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Forte Return On Asset Comparison
Forte Biosciences is currently under evaluation in return on asset category among its peers.
Forte Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Forte Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Forte Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Forte Biosciences' change in net profit over the period of time. It can combine multiple indicators of Forte Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 3.6 K | 3.8 K | |
| Interest Income | 1.1 M | 1.3 M | |
| Operating Income | -32.5 M | -34.1 M | |
| Income Before Tax | -31.5 M | -33 M | |
| Total Other Income Expense Net | 1 M | 1.1 M | |
| Net Loss | -16 M | -16.8 M | |
| Net Loss | -31.5 M | -33 M | |
| Income Tax Expense | -19.6 K | -18.6 K | |
| Net Interest Income | 1.1 M | 1.2 M | |
| Net Loss | -30.5 M | -32 M | |
| Change To Netincome | 4.9 M | 4.7 M | |
| Net Loss | (24.92) | (26.17) | |
| Income Quality | 0.91 | 0.81 | |
| Net Income Per E B T | 0.90 | 0.94 |
Forte Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Forte Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Forte Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Forte Biosciences' important profitability drivers and their relationship over time.
Use Forte Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Forte Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will appreciate offsetting losses from the drop in the long position's value.Forte Biosciences Pair Trading
Forte Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Forte Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Forte Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Forte Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Forte Biosciences to buy it.
The correlation of Forte Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Forte Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Forte Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Forte Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Forte Biosciences position
In addition to having Forte Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.